Brief: HEPALINK 9M Revenue RMB3,796.9 Million
29/10/2026 08:44
BRIEF-HEPALINK 9M Revenue RMB3,796.9 Million Oct 29 (Reuters) - HEPALINK 9M net income attributable RMB 393.9 million.
- 9M revenue RMB 3,796.9 million
Recent news on Shenzhen Hepalink Pharmaceutical
See all newsBrief: HEPALINK 9M Revenue RMB3,796.9 Million
Brief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina